ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Komen Brand Takes Hit After PR Disaster

March 30, 2012

Program Announcements

July 25, 1986

Afinitor Significantly Reduced Tumor Size In TSC-Related Renal Angiomyolipomas

January 25, 2013

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Publications: The Cigarette Papers Available On the Web

September 27, 1996

In Radio Address, Clinton Outlines Administration Priorities

October 2, 1998